Literature DB >> 15158482

Electron microscopy as a quantitative method for investigating tau fibrillization.

Mihaela Necula1, Jeff Kuret.   

Abstract

Fibrillization of tau protein is a hallmark lesion in Alzheimer's disease. To clarify the utility of electron microscopy as a quantitative assay for tau fibrillization in vitro, the interaction between synthetic tau filaments and carbon/formvar-coated grids was characterized in detail. Filament adsorption onto grids was hyperbolic when analyzed as a function of time or bulk protein concentration, with no evidence for competitive displacement or elution from other components in the reaction mixture. Filament length measurements were linear with filament concentration so long as the concentration of total tau protein in the sample was held constant, suggesting that measurement of filament lengths was accurate under these conditions. Furthermore, exponential filament length distributions were not significantly affected by adsorption time or filament concentration, suggesting that preferential binding among filaments of differing lengths was minimal. However, monomeric tau protein was found to be a strong competitor of filament adsorption, indicating that comparison of filament length measurements at different bulk tau concentrations should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158482     DOI: 10.1016/j.ab.2004.02.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  18 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

2.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

3.  Detection and quantification of tau aggregation using a membrane filter assay.

Authors:  Edward Chang; Jeff Kuret
Journal:  Anal Biochem       Date:  2007-09-19       Impact factor: 3.365

4.  Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

Authors:  Erin E Congdon; Sohee Kim; Jonathan Bonchak; Tanakorn Songrug; Anastasios Matzavinos; Jeff Kuret
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

5.  Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps.

Authors:  Edward Chang; Sohee Kim; Haishan Yin; Haikady N Nagaraja; Jeff Kuret
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

6.  Inhibition of Tau aggregation by three Aspergillus nidulans secondary metabolites: 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde.

Authors:  Smita R Paranjape; Yi-Ming Chiang; James F Sanchez; Ruth Entwistle; Clay C C Wang; Berl R Oakley; T Chris Gamblin
Journal:  Planta Med       Date:  2014-01-10       Impact factor: 3.352

7.  Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity.

Authors:  Kristen E Funk; Stefani N Thomas; Kelsey N Schafer; Grace L Cooper; Zhongping Liao; David J Clark; Austin J Yang; Jeff Kuret
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

8.  Differentiating Alzheimer disease-associated aggregates with small molecules.

Authors:  Nicolette S Honson; Ronald L Johnson; Wenwei Huang; James Inglese; Christopher P Austin; Jeff Kuret
Journal:  Neurobiol Dis       Date:  2007-07-28       Impact factor: 5.996

9.  Ligand electronic properties modulate tau filament binding site density.

Authors:  Katryna Cisek; Jordan R Jensen; Nicolette S Honson; Kelsey N Schafer; Grace L Cooper; Jeff Kuret
Journal:  Biophys Chem       Date:  2012-09-11       Impact factor: 2.352

10.  Small-molecule mediated neuroprotection in an in situ model of tauopathy.

Authors:  Nicolette S Honson; Jordan R Jensen; Aida Abraha; Garth F Hall; Jeff Kuret
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.